Internal Bodies

Research Coordination Board

The Research Coordination Board (RCB) is a scientific-strategic body consisting of 40 representatives of the DZD partners and the associated partners. Its task is to coordinate and further develop the scientific DZD program.

Due to its high degree of expertise in the various focus areas of research on prediabetes, type 1 diabetes and type 2 diabetes, this body is ideally positioned to especially take into account the translational research approach. In addition, the RCB assists with the establishment of international networks and helps to increase the visibility of the DZD.

To deepen the expertise in certain areas, guests specialized in the corresponding thematic areas can be invited.

Members

Prof. Dr. Hadi Al-Hasani, DDZ, Düsseldorf

Prof. Dr. Andreas Birkenfeld, IDM, Tübingen

Prof. Dr. Ezio Bonifacio, PLID, Dresden

Prof. Dr. Stefan Bornstein, PLID, Dresden

Prof. Dr. Jens Brüning, UKK, Köln

Prof. Dr. Ünal Coskun, PLID, Dresden

Prof. Dr. Andreas Fritsche, IDM, Tübingen

Prof. Dr. Anthony Gavalas, PLID, Dresden

Prof. Dr. Tilman Grune, DIfE, Potsdam

Prof. Dr. Christian Herder, DDZ, Düsseldorf

Prof. Dr. Stephan Herzig, Helmholtz Munich

Prof. Dr. Dr. h.c. mult. Martin Hrabé de Angelis, Helmholtz Munich

Prof. Dr. Dr. Andrea Icks, DDZ, Düsseldorf

Prof. Dr. Reiner Jumpertz-von Schwartzenberg, IDM, Tübingen

PD Dr. Sabine Kahl, DDZ, Düsseldorf

Prof. Dr. Eckhard Lammert, DDZ, Düsseldorf

Prof. Dr. Heiko Lickert, Helmholtz Munich

Prof. Dr. Barbara Ludwig, PLID, Dresden

Prof. Dr. Knut Mai, DIfE, Potsdam

N.N., UKSH, Lübeck

Prof. Dr. Soyoung Park, DIfE, Potsdam

Prof. Dr. Nikolaos Perakakis, PLID Dresden

Prof. Dr. Andreas Peter, IDM, Tübingen

Prof. Dr. Annette Peters, Helmholtz Munich

Prof. Dr. Hubert Preißl, IDM, Tübingen

Prof. Dr. Olga Ramich, DIfE, Potsdam

Prof. Dr. Dr. h.c. Michael Roden, DDZ, Düsseldorf

PD Dr. Sabrina Schlesinger, DDZ, Düsseldorf

Prof. Dr. Robert Schneider, Helmholtz Munich

Prof. Dr. Tim Schulz, DIfE, Potsdam

Prof. Dr. Matthias Schulze, DIfE, Potsdam

Prof. Dr. Annette Schürmann, DIfE, Potsdam

Prof. Dr. Dr. Michele Solimena, PLID, Dresden

Prof. Dr. Norbert Stefan, IDM,Tübingen

Prof. Dr. Michael Stumvoll, UKL, Leipzig

Prof. Dr. Julia Szendrödi, UKH, Heidelberg

Prof. Dr. Matthias Tschöp, Helmholtz Munich

Prof. Dr. Cora Weigert, IDM,Tübingen

Prof. Dr. Sebastian Wolf, LMU, München

Prof. Dr. Anette-Gabriele Ziegler, Helmholtz Munich

 

 

Clinical Study Board

The DZD Clinical Study Board discusses new studies, topics and issues related to ongoing DZD multicenter studies. The board develops the DZD core data set and regularly standardizes the DZD SOPs.

Directorship of the DZD Clinical Study Board

Prof. Dr. Andreas Birkenfeld, IDM, Tübingen

Prof. Dr. Dr. h.c. Michael Roden, DDZ, Düsseldorf

Members

Dr. Peter Achenbach, Helmholtz Munich

Prof. Dr. Matthias Blüher, UKL, Leipzig

Dr. Michael Faust, UKK, Köln

Dr. Gesine Flehmig, UKL, Leipzig

Prof. Dr. Andreas Fritsche, IDM, Tübingen

Dr. Ruth Hanßen, UKK, Köln

Prof. Dr. Hans Hauner, TUM, München

Dr. Stefan Kabisch, Charité, Berlin

PD Dr. Sabine Kahl, DDZ, Düsseldorf

PD Dr. Stefan Kopf, UKH, Heidelberg

Prof. Dr. Knut Mai, Charité, Berlin

Dr. Svenja Meyhöfer, UKSH, Lübeck

Prof. Dr. Nikolaos Perakakis, UKD, Dresden

Prof. Dr. Peter Schwarz, UKD, Dresden

Prof. Dr. Jochen Seißler, LUM, München

Prof. Dr. Norbert Stefan, UKT, Tübingen

Prof. Dr. Julia Szendrödi, UKH, Heidelberg

Prof. Dr. Robert Wagner, DDZ, Düsseldorf

Prof. Dr. Anette-Gabriele Ziegler, Helmholtz Munich

 

 

Biobanking Board

The Biobanking Board advises the DZD Biobank Management at the DZD head office and is responsible for the implementation of defined strategies and tasks at the partner locations.

Members

Dr. Christian Gieger, Helmholtz Munich

Dr. Stefan Kabisch, Charité, Berlin

Prof. Dr. Andreas Peter, IDM, Tübingen

Dr. David Poitz, PLID, Dresden

Eyke Schöninger, PLID, Dresden

Dr. Sandra Trenkamp, DDZ, Düsseldorf

 

 

Use & Access Committee

The Use & Access Committee evaluates project proposals with regard to the use of biosamples and/or the analysis of data from DZD studies and the DZD biobank. The committee comprises six DZD scientists, who are appointed by the DZD for two years.

Members

Prof. Dr. Caroline Daniel, Helmholtz Munich

Dr. Sabine Kahl, DDZ, Düsseldorf

Prof. Dr. Stephanie Kullmann, IDM, Tübingen

Prof. Dr. Nikolaos Perakakis, PLID, Dresden

Prof. Dr. Olga Ramich, DIfE, Potsdam

Prof. Dr. Julia Szendrödi; UKH, Heidelberg

 

 

Data Management Board

The task of the DZD Data Management Board is to coordinate the overarching approach to DZD data services as well as methods related to the processing, storage and provision of DZD clinical data.

Members

Dr. David Ambrosek, DIfE Potsdam-Rehbrücke

Sonja Hülskämper, IDM, Tübingen

Markus Jähnert, DIfE Potsdam-Rehbrücke

Prof. Dr. Nikolaos Perakakis, PLID, Dresden

Prof. Dr. rer. nat. Hubert Preißl, IDM, Tübingen

Prof. Dr. Rober Wagner, DDZ, Düsseldorf

 

 

DZD NEXT Board

The DZD NEXT Board advises and assists the DZD NEXT Team from the DZD head office in the implementation and further development of the DZD NEXT Young Talent Program.

Members

Prof. Dr. Henriette Kirchner, USHK, Lübeck

Dr. Nikolay Ninov, PLID, Dresden

Dr. Meriem Ouni, DIfE Potsdam-Rehbrücke

Dr. Julia Sbierski-Kind, IDM, Tübingen

Dr. Siegried Ussar, Helmholtz Munich

Dr. Oana-Patricia Zaharia, DDZ, Düsseldorf

 

 

Communication Board

Communicators from the DZD partners and representatives from diabinfo.de exchange information with the central DZD Communication department on issues concerning the press and public relations work and exploit synergies.

Members

Verena Coscia, Helmholtz Munich

Theresa Ester-Nacke, IDM, Tübingen

Ina Henkel, DIfE, Potsdam

Isabell Keller, DDZ, Düsseldorf

Ulrike Koller, diabinfo.de

Dr. Frank Möller, PLID, Dresden

Dr. Olaf Spörkel, diabinfo.de